188 related articles for article (PubMed ID: 12100577)
1. Activation of cyclin-dependent kinases CDC2 and CDK2 in hepatocellular carcinoma.
Li KK; Ng IO; Fan ST; Albrecht JH; Yamashita K; Poon RY
Liver; 2002 Jun; 22(3):259-68. PubMed ID: 12100577
[TBL] [Abstract][Full Text] [Related]
2. On the concentrations of cyclins and cyclin-dependent kinases in extracts of cultured human cells.
Arooz T; Yam CH; Siu WY; Lau A; Li KK; Poon RY
Biochemistry; 2000 Aug; 39(31):9494-501. PubMed ID: 10924145
[TBL] [Abstract][Full Text] [Related]
3. Expression and subcellular localization of CDK2 and cdc2 kinases and their common partner cyclin A in thyroid epithelial cells: comparison of cyclic AMP-dependent and -independent cell cycles.
Baptist M; Lamy F; Gannon J; Hunt T; Dumont JE; Roger PP
J Cell Physiol; 1996 Feb; 166(2):256-73. PubMed ID: 8591985
[TBL] [Abstract][Full Text] [Related]
4. Telomerase activity correlates with cell cycle regulators in human hepatocellular carcinoma.
Hsieh HF; Harn HJ; Chiu SC; Liu YC; Lui WY; Ho LI
Liver; 2000 Apr; 20(2):143-51. PubMed ID: 10847483
[TBL] [Abstract][Full Text] [Related]
5. Degradation of cyclin A does not require its phosphorylation by CDC2 and cyclin-dependent kinase 2.
Yam CH; Siu WY; Lau A; Poon RY
J Biol Chem; 2000 Feb; 275(5):3158-67. PubMed ID: 10652300
[TBL] [Abstract][Full Text] [Related]
6. Hyperoxia induces S-phase cell-cycle arrest and p21(Cip1/Waf1)-independent Cdk2 inhibition in human carcinoma T47D-H3 cells.
Bilodeau JF; Faure R; Piedboeuf B; Mirault ME
Exp Cell Res; 2000 May; 256(2):347-57. PubMed ID: 10772807
[TBL] [Abstract][Full Text] [Related]
7. Effects of phosphorylation by CAK on cyclin binding by CDC2 and CDK2.
Desai D; Wessling HC; Fisher RP; Morgan DO
Mol Cell Biol; 1995 Jan; 15(1):345-50. PubMed ID: 7799941
[TBL] [Abstract][Full Text] [Related]
8. Cyclins and cyclin-dependent kinases: comparative study of hepatocellular carcinoma versus cirrhosis.
Masaki T; Shiratori Y; Rengifo W; Igarashi K; Yamagata M; Kurokohchi K; Uchida N; Miyauchi Y; Yoshiji H; Watanabe S; Omata M; Kuriyama S
Hepatology; 2003 Mar; 37(3):534-43. PubMed ID: 12601350
[TBL] [Abstract][Full Text] [Related]
9. Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes.
Jaumot M; Estanyol JM; Serratosa J; Agell N; Bachs O
Hepatology; 1999 Feb; 29(2):385-95. PubMed ID: 9918914
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the in vitro reconstituted cyclin A or B1-dependent cdk2 and cdc2 kinase activities.
Pan ZQ; Amin A; Hurwitz J
J Biol Chem; 1993 Sep; 268(27):20443-51. PubMed ID: 8397207
[TBL] [Abstract][Full Text] [Related]
11. Reciprocal activation by cyclin-dependent kinases 2 and 7 is directed by substrate specificity determinants outside the T loop.
Garrett S; Barton WA; Knights R; Jin P; Morgan DO; Fisher RP
Mol Cell Biol; 2001 Jan; 21(1):88-99. PubMed ID: 11113184
[TBL] [Abstract][Full Text] [Related]
12. G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells.
Akiyama T; Yoshida T; Tsujita T; Shimizu M; Mizukami T; Okabe M; Akinaga S
Cancer Res; 1997 Apr; 57(8):1495-501. PubMed ID: 9108451
[TBL] [Abstract][Full Text] [Related]
13. Caco-2 intestinal cell differentiation is associated with G1 arrest and suppression of CDK2 and CDK4.
Ding QM; Ko TC; Evers BM
Am J Physiol; 1998 Nov; 275(5):C1193-200. PubMed ID: 9814966
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
Coppock DL; Buffolino P; Kopman C; Nathanson L
Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
[TBL] [Abstract][Full Text] [Related]
15. Characterization of p21Cip1/Waf1 peptide domains required for cyclin E/Cdk2 and PCNA interaction.
Chen IT; Akamatsu M; Smith ML; Lung FD; Duba D; Roller PP; Fornace AJ; O'Connor PM
Oncogene; 1996 Feb; 12(3):595-607. PubMed ID: 8637717
[TBL] [Abstract][Full Text] [Related]
16. Interferon-alpha delays S-phase progression in human hepatocellular carcinoma cells via inhibition of specific cyclin-dependent kinases.
Murphy D; Detjen KM; Welzel M; Wiedenmann B; Rosewicz S
Hepatology; 2001 Feb; 33(2):346-56. PubMed ID: 11172336
[TBL] [Abstract][Full Text] [Related]
17. Xylocydine, a novel Cdk inhibitor, is an effective inducer of apoptosis in hepatocellular carcinoma cells in vitro and in vivo.
Cho SJ; Lee SS; Kim YJ; Park BD; Choi JS; Liu L; Ham YM; Moon Kim B; Lee SK
Cancer Lett; 2010 Jan; 287(2):196-206. PubMed ID: 19616371
[TBL] [Abstract][Full Text] [Related]
18. Amplified CDK2 and cdc2 activities in primary colorectal carcinoma.
Kim JH; Kang MJ; Park CU; Kwak HJ; Hwang Y; Koh GY
Cancer; 1999 Feb; 85(3):546-53. PubMed ID: 10091728
[TBL] [Abstract][Full Text] [Related]
19. Cdc2 and Cdk2 kinase activated by transforming growth factor-beta1 trigger apoptosis through the phosphorylation of retinoblastoma protein in FaO hepatoma cells.
Choi KS; Eom YW; Kang Y; Ha MJ; Rhee H; Yoon JW; Kim SJ
J Biol Chem; 1999 Nov; 274(45):31775-83. PubMed ID: 10542199
[TBL] [Abstract][Full Text] [Related]
20. Reconstitution of cyclin-dependent cdc2 and cdk2 kinase activities in vitro.
Pan ZQ; Hurwitz J
J Biol Chem; 1993 Sep; 268(27):20433-42. PubMed ID: 8397206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
